Tauseef Ali MD, FACG AGAF FACP (@ibdtweets) / X

Tauseef Ali MD, FACG AGAF FACP

12.9K posts

Tauseef Ali MD, FACG AGAF FACP

@ibdtweets

Oklahoma, USA 🇺🇸

ssmhealth.com/ibdcare

Joined December 2011

Pinned
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Nov 4, 2025
Truly honored to be recognized as a 2025 Social Media Influencer by Healio Disruptive Innovators in collaboration with Healio Community. Social media has evolved into a powerful tool for medical education — a place to learn, teach, connect, and advocate. For me, it’s about
3.9K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Oct 15, 2022
First copy of my book landed! A book written with passion, enthusiasm. Dedicating to all my patients who taught me alot during their journey with this illness. Thanks @IBDMD for foreward and @ibdgijami for technical edition @CrohnsColitisFn @AmerGastroAssn @AmCollegeGastro
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Aug 29, 2024
IL-23 inhibitors can significantly improve Crohn's colitis, leading to remarkable bowel healing. This promising advance brings hope for better long-term outcomes in Crohn's disease.
16K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Apr 4, 2022
Finally a dream coming true! Official launch of our comprehensive Crohn’s and Colitis Center with many services under one roof ! For the patients. Ladies and gentlemen, I present to you our newly established Crohn’s and Colitis Center. Many more good news to come in future.
SSM Health St. Anthony Hospital
@SSMHealthSaints
Apr 4, 2022
Crohn’s and Colitis can be overwhelming. At our new Crohn’s & Colitis Center, nationally respected inflammatory bowel disease (IBD) specialists (like @IBDTweets) are here to help. Learn more at youtu.be/W3kyNkRPlZM.
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Oct 27, 2024
Don't under-treat moderate to severe UC patients.#ACG2024
20K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Nov 11, 2021
A very humbling experience, and thankful to all support of my family, friends and colleagues. I dedicate this award to all my patients !! 🙏
SSM Health St. Anthony Hospital
@SSMHealthSaints
Nov 11, 2021
Congrats to Tauseef Ali, MD, gastroenterologist, recipient of the 2021 St. Luke Award! The award is given each year by St. Anthony Hospital executives to the physician who most exemplifies the life of St. Luke, The Patron Saint of Physicians & Surgeons. #saintsinaction @ibdtweets
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Apr 3, 2024
I am truly honored by my patients and colleagues to receive this award. A very humbling experience! I dedicate this ward to my beloved IBD patients ❤️ Thank you, @CrohnsColitisFn, for supporting and advocating for IBD patients @SSMHealthSaints @SSMHealth
11K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Sep 18, 2022
Proudly presenting 2nd Ed Crohn’s and Colitis for Dummies. A book written for patients, friends, families and caregivers with updated chapter contents. Many thanks to @ibdgijami as technical editor and gratitude to @IBDMD for writing Foreward #1 New Release in Gastroenterology
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Nov 19, 2023
Know your mesalamine! A quick guide to mesalamine for UC in IBD #ibd101
14K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Jun 21, 2025
Fecal Calprotectin 101 by @MaiaKayalMD during #aibdregionals25 @AmCollegeGastro
10K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
May 17, 2025
Fibrostenosing Crohn’s disease is a tough challenge 🔗10% of patients present with fibrosis at diagnosis 🔗50% develop strictures over time 🔗70% need surgery — and many redevelop disease post-op The cause? Still unclear. But scientists are digging into ECM expansion and
7.8K
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Jan 2, 2021
STRIDE-II: Here is a slide summary of Crohn's Disease Targets @IbdClub. By @IOIBD1 @IBDMD @ibddocmaria et al An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the … pubmed.ncbi.nlm.nih.gov/33359090/
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Jun 28, 2021
NEW @AmCollegeGastro C DIFF Guidelines. Lets compare with older 2013's one ! Well we got the name change to begin with. Its Clost-tri-diodes Difficile now! @AmJGastro @DrStollman @DrJessicaA @gastrogirl @gastroendonews @HealioGastro @ibdclub
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Jun 1, 2025
✅ Vedolizumab: Summary of Key Clinical Trials 🔹 GEMINI 1 & 2 IV vedolizumab is effective for: – UC: Strong induction & maintenance – CD: Modest induction, robust maintenance 🔹 EARNEST 📊 First RCT showing efficacy in chronic pouchitis, supporting post-IPAA use. 🔹 REPREVIO 🔁
6.7K